Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TNB-738 by Ancora Biotech for Unspecified Metabolic Disorders: Likelihood of Approval
TNB-738 is under clinical development by Ancora Biotech and currently in Phase I for Unspecified Metabolic Disorders. According to GlobalData,...
TNB-738 by Ancora Biotech for Autoimmune Disorders: Likelihood of Approval
TNB-738 is under clinical development by Ancora Biotech and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...
TNB-738 by Ancora Biotech for Unspecified Immunological Disorders: Likelihood of Approval
TNB-738 is under clinical development by Ancora Biotech and currently in Phase I for Unspecified Immunological Disorders. According to GlobalData,...